{"version":"1.0","type":"link","title":"The novel oncogenic factor TET3 combines with AHR to promote thyroid cancer lymphangiogenesis via the HIF-1α/VEGF signaling pathway.","author_name":"Yang L 외","author_url":"https://prs-insight.online/author/Yang%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/145151","thumbnail_width":1200,"thumbnail_height":630}